Advancements in Gene Editing Technology and Expansion of Oncology Research to Expand Demand for Humanized Mice ModelsRockville, MD, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The humanized mice model market is ...
Tubulis announced today that its second drug candidate, TUB-030, has entered clinical evaluation with successful dosing of the first patient in the 5-STAR 1-01 Phase I/IIa trial (NCT06657222). The ...